TITXF Stock UPDATES Titan Medical Inc (TITXF) 2.1810 09/09/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Titan Medical Inc (TITXF) 2.1810 $TITXF

Titan Medical Inc. Appoints Dr. Dennis Fowler as Executive Vice President, Clinical and Regulatory Affairs
Marketwire - Tue Sep 09, 6:03AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) today announced that Dr. Dennis Fowler, who currently serves as the Company's Director of Clinical Affairs, has been appointed to the newly-created position of Executive Vice President, Clinical and Regulatory Affairs.

Titan Medical Inc. Announces DTC Eligibility
Marketwire - Wed Sep 03, 6:01AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today that the Depository Trust Company (DTC) has approved the Company's eligibility application for Titan Medical Inc. (CUSIP 88830X108), effective August 21, 2014.

Titan Medical Inc. Announces Results for the Three and Six Months Ended June 30, 2014
Marketwire - Wed Aug 13, 8:46AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today financial results for the three and six months ended June 30, 2014. All financial results are reported in U.S. dollars, unless otherwise stated.

With Only One Product to Hope For, the Source of Downside Risks Are Numerous and Diverse; Analyst Report by BrokerBank Securities, Inc.
PR Newswire - Mon Jun 30, 1:30PM CDT
Titan Medical Inc. (OTCQX: TITXF) is a venture company with a market capitalization of about $200 million. Headquartered in Toronto, Canada. The company is involved in building a robotic surgical tool for application in minimally invasive surgery ("MIS" . The key concept of MIS is to minimize the incision area during the surgical operation. In general, MIS leads to quicker recovery, shorter hospital stays, less pain, fewer and smaller scars, reduced risk of infection, and less blood loss.

Titan Medical Inc. Corporate Update
Marketwire Canada - Mon Jun 30, 6:00AM CDT
Titan Medical Inc. (the "Company" (TSX VENTURE:TMD) (OTCQX:TITXF) announced today that Mr. Joe Talarico, Senior Vice President Business Development has resigned his position with the Company. We would like to thank Joe for his contribution to Titan during his four years with the Company. In the interim John Hargrove, Chairman and CEO will assume the responsibilities for Business Development.

Titan Medical Inc. Retains New York-Based Bertner Advisors, LLC for Investor Relations Services
Marketwire - Wed Jun 18, 1:29AM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today that it has retained Bertner Advisors, LLC as its investor relations advisor. Services to be provided in the United States to Titan by Bertner Advisors include counsel on investor relations strategy.

Titan Medical Inc. Announces Completion of Key Milestone in the Development of Its SPORT(TM) Surgical System
Marketwire - Mon Jun 16, 6:01AM CDT
Titan Medical Inc. (the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today that it successfully completed animal tissue studies on May 30, 2014, performing a full cholecystectomy (gallbladder removal) procedure using the SPORT Surgical System alpha commercial prototype for the required surgical tasks (including grasping, dissecting, mono-polar cautery and suturing). This comes after the recent successful completion of the Q1 2014 milestone of completing an alpha commercial prototype. "We are most pleased to confirm this key milestone of the successful completion of an actual non-human surgical procedure. The procedure was extensively validated by reviewing video footage of the surgical field and instruments from several viewing angles," said John Hargrove, Titan Medical Chairman and CEO. He further stated, "This is what we expected and targeted for our goals-we have a great team, a great technology and a tremendous opportunity. The development of the SPORT Surgical System remains on schedule."

Medical Robots Market by Type & Application - Global Forecasts to 2018 for the $1,781 Million Market
M2 - Fri Mar 21, 9:29AM CDT
Research and Markets (http://www.researchandmarkets.com/research/mwj8xd/medical_robots) has announced the addition of the "Medical Robots Market by Type (Surgical Robot, Rehabilitation Robotics, Telemedicine, Assistive Robots, Orthotics, Prosthetics, Radio Surgery, Exoskeleton) & Application (Orthopedic, Neurology, Laparoscopy)- Global Forecasts to 2018" report to their offering. The medical robotics market was valued at $1,781 million in 2013 and is expected to reach $3,764 million by 2018, growing at a CAGR of 16.1% from 2013 to 2018 Over the years, the demand for medical robots has increased significantly. This is due to the paradigm shift in the healthcare industry where emphasis is being laid on minimally invasive surgeries through the use of robots. The global medical robot market is categorized into five broad segments - surgical robots, rehabilitation robots, non-invasive radiosurgery robots, hospital and pharmacy robots, and others. Based on applications, the medical robots market comprises the following segments - neurology, orthopedics, laparoscopy, special education, and other areas. . The hospital and pharmacy robots segment is the fastest-growing segment of the medical robotics market. The increasing demand for telemedicine robots is likely to propel the growth of this market. Along with this, technological developments and increasing adoption of newer technologies by hospitals are some factors that are propelling the demand for hospital and pharmacy robots. The other major segment under hospital and pharmacy robots is the i.v. robots segment. i.v. robots are dispensing robots used in hospitals and pharmacies to accurately compound drug mixtures. These robots are used to administer safe, accurate, efficient, cost-effective, and ready-to-administer IV admixtures. Factors such as an aging population, increasing spending power of the middle-class population, increasing number of private sector hospitals, advancements in endoscopic technologies, and expansions of rural healthcare facilities are also going to play a pivotal role in boosting the demand for medical robotics in the Asian region. China and Japan will be the focal point for the growth of medical robotics in the Asian market. Countries such as Singapore and Thailand are also expected to witness growth in this sector, owing to increasing government support. North America and Europe are both likely to witness an increasing demand for medical robotics owing to technological advancements as well as increased government support in both the geographies. Scope of the Report Segment - Surgical Robots -- Orthopedic Surgical Robots -- Neurological Surgical Systems -- Laparoscopy Robotic Systems -- Steerable Robotic Catheters - Rehabilitation Robots -- Assistive Robots -- Prosthetics -- Orthotics -- Therapeutic Robots -- Exoskeleton Robotic Systems - Non-Invasive Radio surgery Robots - Hospital and Pharmacy Robots -- Telemedicine Robots -- I.V. Robots -- Pharmacy Robots - Others Application - Neurology - Orthopedics - Laparoscopy - Special Education - Others Companies Mentioned - Accuray, Inc. - Hansen Medical, Inc. - Health Robotics S.R.L. - Intuitive Surgical Inc. - Mako Surgical Corp. - Mazor Robotics Ltd. - Medrobotics Corporation - Or Productivity Plc - Renishaw Plc - Titan Medical Inc. For more information visit http://www.researchandmarkets.com/research/mw...cal_robots

Titan Medical Inc. Appoints Dr. Bruce Wolff to the Board of Directors
Marketwire - Tue Mar 11, 3:04PM CDT
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) is pleased to announce that Dr. Bruce Giles Wolff, M. D., Professor of Surgery, Mayo Clinic College of Medicine and Emeritus Chair of the Division of Colon & Rectal Surgery, Mayo Clinic - Rochester, Minn., has been appointed to the Board of Directors. Dr. Wolff has been a member of the Mayo Clinic's Surgical Administrative Committee since 2006. Dr. Wolff is a former President of the American Society of Colon and Rectal Surgeons, a former Director and President of the American Board of Colon and Rectal Surgery, and a former Vice President and Director of the Foundation for Surgical Fellowships. Dr. Wolff has written extensively on colon and rectal surgery issues in almost 300 articles for publications such as The American Journal of Surgery, the Canadian Journal of Surgery, the World Journal of Surgery, Mayo Clinic Proceedings, the America Surgeon, the Journal of Gastrointestinal Surgery, Diseases of the Colon & Rectum, Annals of Surgery and the British Journal of Surgery.

Titan Medical Inc. Announces Results for Fiscal Year Ended December 31, 2013
Marketwire - Thu Mar 06, 4:54PM CST
Titan Medical Inc. ("Titan" or the "Company" (TSX VENTURE: TMD)(OTCQX: TITXF) announced today its results for the fiscal year ended December 31, 2013.

IIROC Trading Resumption - TMD, TMD.WT, TMD.WT.A, TMD.WT.B, TMD.WT.C
CNW Group - Wed Feb 19, 9:56AM CST
Trading resumes in:

IIROC Trading Halt - TMD, TMD.WT, TMD.WT.A, TMD.WT.B, TMD.WT.C
CNW Group - Wed Feb 19, 8:39AM CST
The following issues have been halted by IIROC:

IIROC Trade Halt - Titan Medical Inc.
Newsfile Corp - Wed Feb 19, 8:35AM CST
The following issues have been halted by IIROC:




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors, Portillo's Fraud Claims Demand Your Attention

Updated Category News Views 30

Portillo's Investors Caught in a Tough Spot Ah, Portillo's. You thought those hot dogs were the only spicy thing you're biting into? Try these allegations on for size. Investors are biting back with a securities fraud lawsuit, and the details are saltier than a bucket of fries. The folks who held PTLO shares between September 19, 2023, and May 4, 2026, are in the...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 69

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
A&G Management's Bold New Era with WPM Partnership

Updated Category News Views 122

Shaking Up Baltimore's Real Estate Scene Swapping up management partners can be a dicey game, but A&G Management seems to be pulling it off without a hitch. As of January 4, 2027, WPM Real Estate Management will take over the reins for more than 3,000 apartment homes scattered across Anne Arundel, Howard, and Baltimore counties. A new set of hands is stepping in for...

Continue Reading
Duolingo Faces Class Action: Key Investor Steps

Updated Category News Views 110

Navigating Turbulent Times with Duolingo Holy moly, the dumpster fire that is the Duolingo (NASDAQ:DUOL) legal saga just got hotter. If you snagged yourself some shares between May 2, 2025, and February 26, 2026, you'd better sit down and grab some antacids—because the nauseating roller coaster is far from over. Robbins LLP is rounding up the troops for a class action,...

Continue Reading
DEFSEC Completes 9-to-1 Share Consolidation

Updated Category News Views 79

DEFSEC Technologies Tightens the Belt So, DEFSEC Technologies just pulled off something that'll kick up dust among investors. A 9-to-1 share consolidation—now that's no small fry. For those riding the NASDAQ or the TSX Venture with a tight grip on their DEFSEC shares, it's strictly business today. Post-consolidation, DEFSEC's common shares are set to trade under the...

Continue Reading
IP Lawyer Chris Henry Returns to Latham: A Game Changer

Updated Category News Views 106

Welcome Home, Chris Henry! Folks, here's a headline that's making waves in the IP litigation water: Chris Henry has returned to Latham & Watkins, taking his place as a heavyweight partner in their Boston office. Now, if you're not deeply entangled in the world of high-stakes intellectual property (IP) disputes, you might shrug. But for tech companies embroiled in patent...

Continue Reading
BETR's Legal Tangle: A Deeper Dive into Investor Turmoil

Updated Category News Views 52

BETR's Shaky Ground: When Promises Fall Short In the rough-and-tumble world of finance, there's little room for empty promises. Better Home & Finance Holding Company (NASDAQ: BETR) might have to learn that the hard way. Investors who snagged shares between March 13 and August 6, 2026, are now clutching their heads as they watch their investments nosedive. When companies...

Continue Reading
Portillo's Faces Legal Heat: Investor Class Action Filed

Updated Category News Views 101

What’s Eating Portillo's? Ah, once upon a misstep in the land of promising expansion, now we have Portillo's Inc. (NASDAQ: PTLO) neck-deep in legal hot water. Those golden fries and famous sandwiches somehow didn't pave the way for stockholder bliss. Why the turmoil? On an ordinary November morning, the DJS Law Group made it clear: They're rallying the troops for a...

Continue Reading
Painter's Accessory Aims to Revolutionize Convenience

Updated Category News Views 64

Crafty New Invention Targets Painters' Ease Ever find yourself tangled in paintbrushes and rollers while trying to get that perfect coat on the wall? Well, a painter from Bracebridge, Ontario, has had it with the struggle and is looking to stir the pot with their latest invention, the NU LIFE LINER. It's sleek, it's practical, and it's aimed at flipping the painting game...

Continue Reading
Palatin's Game-Changer: MC4R Agonist Hits the Stage

Updated Category News Views 83

Breaking New Ground in Obesity Treatment Palatin Technologies is stepping into the spotlight with some heavy ammunition in the fight against obesity. The company has just unveiled impressive preclinical data about their next-generation melanocortin-4 receptor (MC4R) agonists at the ObesityWeek® 2026 conference. This isn’t just your run-of-the-mill corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

ROHM's AI-Driven Microcontrollers Revolutionize Machine Efficiency

Updated Category News Views 265

Introduction to ROHM's Innovative AI MCUs In a groundbreaking announcement, ROHM Semiconductor has unveiled a new line of microcontrollers (MCUs) equipped with advanced artificial intelligence capabilities. These AI-enabled MCUs are designed to optimize machine performance and proactively predict equipment failures by analyzing real-time data. ROHM's new technology...

Continue Reading
Nvidia Clarifies Investment Strategy Amid Market Uncertainty

Updated Category News Views 237

Nvidia Stock Reacts to New Clarifications on Investment NVIDIA Corporation (NASDAQ: NVDA) experienced a slight dip in premarket trading as investors responded to CEO Jensen Huang's recent statements about the company's potential engagement with OpenAI. Huang, addressing reporters in Taipei, clarified that the previously mentioned $100 billion was not a binding commitment...

Continue Reading
CPTx Strengthens Leadership with New CFO Appointment

Updated Category News Views 223

CPTx Welcomes McDavid Stilwell as Chief Financial Officer In a significant move to bolster its strategic and financial expertise, CPTx GmbH has appointed McDavid Stilwell as its new Chief Financial Officer (CFO). With a wealth of experience in finance and corporate strategy, Mr. Stilwell's leadership is expected to play a crucial role as the company works towards...

Continue Reading
Jupiter Neurosciences Celebrates Key Milestones in Growth Journey

Updated Category News Views 163

Jupiter Neurosciences Celebrates Key Milestones in Growth Journey Company advances JOTROL into Phase 2a Parkinson’s trial, launches Nugevia consumer brand, and strengthens financial position As Jupiter Neurosciences embarks on the journey into 2026, its first full year as a public company marks a pivotal moment. The company, known for its development of JOTROL, a...

Continue Reading
Challenges Ahead: Indian Corporate Earnings Growth Slows

Updated Category News Views 143

Indian Corporate Earnings Growth Faces Slowdown Recent insights from analysts reveal that Indian corporate earnings growth is expected to reach a three-year low. The slowdown is primarily attributed to weak performance across various sectors, as indicated in a note by Morgan Stanley. The once persistent upcycle of double-digit earnings growth appears to be stalling,...

Continue Reading